For laboratory research use only. Not for human consumption.
Free cold-chain shipping over $200 CAD · Ships from Kelowna, BC

Lumera Labs Journal · Compendium

LL-37: cathelicidin antimicrobial-peptide research notes

Published 2024-10-18 · Lumera Labs Editorial · Kelowna, BC

Short answer. LL-37 is the 37-residue cleavage fragment of human cathelicidin antimicrobial protein hCAP-18. The amphipathic α-helix is investigated in in-vitro membrane-disruption and antimicrobial-pathway research. Lumera ships HPLC-verified LL-37 from $55 CAD.

Sequence and structure

LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES — 37 residues, mass 4493.34 Da. Adopts an amphipathic α-helix in membrane-mimetic environments, with hydrophobic residues clustering on one face and cationic residues on the other. The amphipathicity drives the membrane-perturbing activity that defines the cathelicidin class.

Synthesis challenges

LL-37 is one of the harder peptides on a research catalog to synthesize cleanly:

  • Aggregation in synthesis: the long hydrophobic stretches drive coupling-step interruptions; double-couplings on residues 12–18 are routine.
  • Aspartimide formation: the Asp-Gly motif at positions 26–27 is aspartimide-prone; synthesis cocktails should include 0.1 M HOBt to suppress.
  • HPLC retention: high hydrophobicity means LL-37 elutes late on standard C18 gradients; columns benefit from extended conditioning between injections.

Reference-grade quality criteria

  • RP-HPLC purity ≥ 99% at 220 nm.
  • ESI-MS at 4493.34 Da ± 0.5 Da.
  • Aspartimide content < 1.5% (key impurity for this sequence).
  • Net peptide content ≥ 80% by AAA.
  • Endotoxin < 0.5 EU/mg.

Reconstitution

LL-37 is moderately surface-active and adheres to plastic. Reconstitute in bacteriostatic water at 1 mg/mL or higher; lower concentrations show measurable loss to pipette tips. Use low-binding tubes for aliquots. Stable 14 days at 2–8 °C; longer storage as −80 °C aliquots with single freeze-thaw protocol.

Lumera Labs ships HPLC-verified LL-37 cold-chain across Canada from $55 CAD. View LL-37 on the catalog →


Frequently asked questions

Is LL-37 hard to make?

Relative to short research peptides, yes — the long hydrophobic stretches and aspartimide-prone Asp-Gly motif require attentive synthesis. Reference-grade lots typically run higher than $50 CAD per 10 mg vial.

What is LL-37's mass?

Theoretical 4493.34 Da. ESI-MS confirmation should fall within 0.5 Da on a competent COA.

Why is aspartimide content tracked?

The Asp-Gly motif at positions 26–27 is prone to forming aspartimide during synthesis. Reference-grade material should report < 1.5% aspartimide impurity.

How does LL-37 differ from KPV?

LL-37 is a 37-residue cathelicidin with direct membrane-disruption activity. KPV is a 3-residue α-MSH fragment with cytokine-pathway effects. Different mechanism, different size class.

Where to source LL-37 in Canada?

Lumera Labs ships HPLC-verified LL-37 cold-chain from Kelowna at /products/ll-37/ from $55 CAD.


Disclaimer: All Lumera Labs products are supplied for laboratory research use only. They are not approved by Health Canada for human consumption, therapy, or diagnosis. See our research-use declaration for full terms.

Browse the catalog →